Corrective Phases R...
Health Care: Drugs
Corcept Therapeutics Inc. (CORT: NASDAQ)
$4.08 -0.01 | -0.24%
06/01/12 - 04:00 PM ET
Ratio Comparisons
| Company | Industry | S&P 500 | |
| Valuation Ratios | |||
|---|---|---|---|
| P/E Ratio (TTM) | n.a. | 75.30 | 17.70 |
| P/E High - Last 5 Yrs | n.a. | n.a. | 67.70 |
| P/E Low - Last 5 Yrs | n.a. | n.a. | 12.50 |
| Beta | 0.74 | 0.58 | 0.98 |
| Price to Sales (TTM) | 0.00 | 4.62 | 1.42 |
| Price to Book (MRQ) | 9.20 | 3.44 | 2.41 |
| Price to Tangible Book (MRQ) | 9.20 | 6.74 | 5.08 |
| Price to Cash Flow (TTM) | -10.00 | 26.10 | 9.80 |
| Price to Free Cash Flow (TTM) | -11.90 | 48.80 | 17.40 |
| Dividends | |||
| Dividend Yield (%) | 0.00 | 0.50 | 2.10 |
| Dividend Yield - 5 Yr Avg (%) | n.a. | 0.20 | 2.20 |
| Dividend 5 Yr Growth Rate (%) | n.a. | n.a. | -0.76 |
| Payout Ratio (TTM) | 0.00 | 3.00 | 30.00 |
| Sales (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 9.90 | 11.80 |
| Sales (TTM) vs TTM 1 Yr Ago (%) | n.a. | 7.70 | 9.20 |
| Growth Rates (%) | |||
| Sales - 5 Yr Growth Rate (%) | n.a. | 9.03 | 1.79 |
| EPS (MRQ) vs Qtr 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS (TTM) vs TTM 1 Yr Ago (%) | n.a. | 18.50 | 17.50 |
| EPS - 5 Yr Growth Rate (%) | n.a. | n.a. | -1.66 |
| Capital Spending - 5 Yr Growth Rate (%) | n.a. | -4.13 | -1.17 |
| Financial Strength | |||
| Quick Ratio (MRQ) | 11.00 | 2.90 | 1.10 |
| Current Ratio (MRQ) | 12.00 | 3.50 | 1.60 |
| LT Debt to Equity (MRQ) | 0.00 | 0.41 | 0.82 |
| Total Debt to Equity (MRQ) | 0.00 | 0.45 | 0.96 |
| Interest Coverage (TTM) | n.a. | 6.20 | 5.50 |
| Profitability Ratios (%) | |||
| Gross Margin (TTM) | n.a. | 84.10 | 46.90 |
| Gross Margin - 5 Yr Avg | n.a. | 83.50 | 47.70 |
| EBITD Margin (TTM) | n.a. | 27.30 | 18.90 |
| EBITD - 5 Yr Avg | -16,998.61 | 0.00 | 0.00 |
| Pre-Tax Margin (TTM) | n.a. | 14.10 | 12.10 |
| Pre-Tax Margin - 5 Yr Avg | n.a. | 10.60 | 10.30 |
| Management Effectiveness (%) | |||
| Net Profit Margin (TTM) | n.a. | 0.10 | 0.09 |
| Net Profit Margin - 5 Yr Avg | n.a. | 5.30 | 7.00 |
| Return on Assets (TTM) | -84.60 | 4.70 | 3.10 |
| Return on Assets - 5 Yr Avg | -86.70 | 2.20 | 2.50 |
| Return on Investment (TTM) | -92.00 | 6.10 | 7.90 |
| Return on Investment - 5 Yr Avg | -100.00 | 2.80 | 6.50 |
| Efficiency | |||
| Revenue/Employee (TTM) | 0.00 | 701,747.00 | 449,376.00 |
| Net Income/Employee (TTM) | -117,054.00 | 83,589.00 | 39,003.00 |
| Receivable Turnover (TTM) | n.a. | 5.80 | 7.60 |
| Inventory Turnover (TTM) | -0.20 | 1.30 | 8.30 |
| Asset Turnover (TTM) | 0.00 | 0.40 | 0.40 |
Portfolios with CORT
- Portfolio NameUser Type
- Userwayne120
- Userespwes06 Portfolio 1
- ContributorStocks Under-$10 Moving Hig...
- ContributorTop 10 'Buy'-Rated Stocks U...
- ContributorBarron's Insider Purchases ...
- ContributorBarron's Insider Purchases ...
- Userrubylu02
- UserBarron's Insider Purchases ...
- Usermicahw29 Portfolio 1
- Userrktjky Portfolio 1
Latest CORT Headlines from TheStreet
- Corcept Has Upside Following Drug Approval 02.21.12 | 12:02 pm
- 7 Stocks Under $10 Moving Higher 02.16.12 | 02:02 pm
- These Drugs Stocks Will Win FDA Approval 02.16.12 | 12:02 pm
- Biotech Stock Mailbag: Corcept Therapeutics, Reader Retorts 02.10.12 | 07:02 am
- Play TheStreet's FDA Drug-Approval Contest 01.23.12 | 08:01 am
- 27 Hot Drugs Facing FDA Approval in 2012 12.19.11 | 10:12 am
- Biotech Calendar: Key Dates for March 03.02.11 | 08:03 am
- Danver Bancorp, Dean Foods: Small-Cap Winners 01.21.11 | 01:01 pm
- Biotech Calendar: Key Dates for December 11.30.10 | 07:11 am
- Novartis Cushing's Drug Passes Late-Stage Test 09.22.10 | 07:09 am
Press Releases for CORT
Partner Headlines for CORT
- Company News for February 22, 2012 - Corporate Summary - Zacks 02.22.12 | 10:02 am
- UPDATE: Stifel Nicolaus Increases Target to $9 on Concept Therepeutics - Benzinga 02.21.12 | 09:02 am
- 12 Healthcare Companies Expecting Major February Catalysts - Seeking Alpha 02.01.12 | 07:02 am
- Upcoming PDUFA Dates for Sub-$5 Stocks - Seeking Alpha 07.05.11 | 09:07 am
- 14 Oversold Stocks With Bearish Options - Seeking Alpha 07.01.11 | 08:07 am
- 10 Undervalued Biotech Stocks With Insider Buying - Seeking Alpha 06.23.11 | 06:06 am
- 7 Small-Cap Biotechs With Bullish Insider Buying in 2011 - Seeking Alpha 06.12.11 | 05:06 am
- Low Beta Ideas: 22 High Growth, Low Beta Stocks Being Snapped Up by Mutual Funds - Seeking Alpha 06.09.11 | 09:06 am
- Upgrades, Downgrades and Initiations for Monday - Seeking Alpha 06.06.11 | 09:06 am
- UPDATE 2-Corcept hormone disorder drug meets main trial goal - Reuters 12.22.10 | 11:12 am
